NC-Stat should start growing revenues at a lower margin. Ascend should be launched. Nuro will be a drug company and begin trials with nerve repair compounds. Andara will probably be a product for 2011. This company has a lot of exciting things going for which will be seen in 2010. Hold tight and profit.
nuro would be in a great situation today if they didnt try to cheat the market... And all now with Obama looking to reduce the cost of medicine...I wonder will the damage done by the last COO keep good things from happening to nuro tomorrow?
No, It looks like some insurances prefer NC Stat being used over traditional nerve testing. Stat will get coding for specific tests and Nurometric will have to lower their margins to make it profitable for doctors. At that point in 2010 stat will start growing healtily again. NURO can be profitable again in 2010. All the small caps have moved off of their low and the trend is up while we wait. Not too bad but not for the conservative. There are still risks involved.